These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24144522)

  • 1. [Ocular involvement in familial amyloid polyneuropathy].
    Rousseau A; Kaswin G; Adams D; Cauquil C; Théaudin M; Mincheva Z; M'garrech M; Labetoulle M; Barreau E
    J Fr Ophtalmol; 2013 Nov; 36(9):779-88. PubMed ID: 24144522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The ocular involvement in the transthyretin-related familial amyloid polyneuropathy].
    Lin HY; Dai RP
    Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):783-785. PubMed ID: 29050191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Said G
    Lancet Neurol; 2011 Dec; 10(12):1086-97. PubMed ID: 22094129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver transplantation for familial amyloid polyneuropathy].
    Adams D; Slama M; Samuel D
    Presse Med; 2010 Jan; 39(1):17-25. PubMed ID: 19419835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary glaucoma in patients with familial amyloidotic polyneuropathy.
    Kimura A; Ando E; Fukushima M; Koga T; Hirata A; Arimura K; Ando Y; Negi A; Tanihara H
    Arch Ophthalmol; 2003 Mar; 121(3):351-6. PubMed ID: 12617705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of familial amyloid polyneuropathy].
    Adams D; Samuel D; Slama M
    Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of TTR-FAP in Portugal.
    Conceição I
    Amyloid; 2012 Jun; 19 Suppl 1():71-2. PubMed ID: 22480206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial amyloid polyneuropathies: therapeutic issues].
    Adams D; Cauquil C; Théaudin M
    Bull Acad Natl Med; 2012 Oct; 196(7):1333-45; discussion 1345-7. PubMed ID: 23815018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
    Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R
    Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial amyloid polyneuropathy].
    Yamashita T; Ando Y; Uchino M
    Brain Nerve; 2011 Jun; 63(6):583-95. PubMed ID: 21613661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
    Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S
    J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial amyloid polyneuropathy: clinicopathological aspects].
    Koike H; Sobue G
    Brain Nerve; 2014 Jul; 66(7):749-62. PubMed ID: 24998820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
    Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
    Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset familial amyloid polyneuropathy in Japan.
    Koike H; Sobue G
    Amyloid; 2012 Jun; 19 Suppl 1():55-7. PubMed ID: 22506939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Kerschen P
    Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
    Planté-Bordeneuve V; Ferreira A; Lalu T; Zaros C; Lacroix C; Adams D; Said G
    Neurology; 2007 Aug; 69(7):693-8. PubMed ID: 17698792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy.
    Sandgren O; Kjellgren D; Suhr OB
    Acta Ophthalmol; 2008 Aug; 86(5):520-4. PubMed ID: 18435819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.